Adiponil is a brand of orlistat, an anti-obesity medicine that works in the gut to reduce the amount of fat absorbed from food. It comes as a 120 mg capsule from Incepta Pharmaceuticals Ltd.
There are 5 brands of Orlistat listed in Bangladesh. By unit price, Adiponil is among the cheapest of them.
What is Adiponil 120 mg Capsule?
Adiponil 120 mg Capsule contains orlistat, a medicine classified as an anti-obesity drug. It acts in the stomach and upper small intestine by blocking lipase enzymes, so some dietary fat is not broken down and absorbed. That undigested fat passes out in the stool, which can help support weight control when combined with a mildly reduced-calorie diet. It is meant for adults who are obese, and for overweight adults who also have related risk factors such as type 2 diabetes, high blood lipids or high blood pressure. Whether it suits you depends on your health, so discuss it with your doctor.
Uses of Adiponil
Adiponil is used alongside a mildly reduced-calorie diet to help manage weight in adults who are obese. It is also used in overweight adults who have associated risk factors such as type 2 diabetes, high blood lipids or high blood pressure. It is not a weight-loss medicine for everyone, and your doctor will decide whether it is appropriate for you after assessing your body weight, health status and other conditions.
How to use Adiponil
Take Adiponil as your doctor instructs. The dose, timing and length of the course are decided by your doctor, so follow that advice rather than setting your own schedule. Swallow the capsule with water. If you miss a meal or your meal contains no fat, ask your doctor what to do about that dose. Do not change the amount or stop the course without checking with your doctor or pharmacist first.
Side effects of Adiponil
Most unwanted effects of orlistat are digestive. Common ones include oily spotting from the rectum, passing wind, a sudden need to go to the toilet, oily or fatty stools, and abdominal discomfort. Less often, headache, tiredness, anxiety or flu-like symptoms may occur. Rarely, allergic reactions such as itching, rash, hives or swelling can happen. Tell your doctor if side effects bother you or do not settle.
Safety and precautions
Before starting Adiponil, your doctor should rule out medical causes of obesity such as an underactive thyroid. It should not be used by people with chronic malabsorption, with cholestasis, or with an allergy to orlistat or any ingredient of the capsule. It should not be used during breastfeeding, and there is no clinical data on its use in pregnancy, so discuss pregnancy and contraception with your doctor. If you take ciclosporin or diabetes medicines, tell your doctor, as adjustments or monitoring may be needed.
Frequently asked questions
What is the price of Adiponil 120 mg Capsule?
The listed price is ৳ 40.00. Ask your pharmacist about the current price and any available pack sizes before buying.
Is Adiponil safe in pregnancy or breastfeeding?
It should not be used during breastfeeding. There is no clinical data on its use in pregnancy, so do not take it if you are pregnant or planning pregnancy without first asking your doctor.
What is Adiponil used for and what kind of medicine is it?
It is an anti-obesity medicine containing orlistat. It is used with a mildly reduced-calorie diet to help manage weight in obese adults and in overweight adults with risk factors such as type 2 diabetes, high blood lipids or high blood pressure.
How should I store Adiponil?
Store it in a cool, dry place below 30°C, protected from light and moisture, and keep it out of reach of children. Ask your pharmacist if you are unsure how to dispose of unused capsules.
Adults: Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI)>30 kg/m2 and overweight patients (BMI >28 kg/m2 ) with associated risk factors such as type II diabetes, hyperlipidemia ... Read moreAdults: Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI)>30 kg/m2 and overweight patients (BMI >28 kg/m2 ) with associated risk factors such as type II diabetes, hyperlipidemia and hypertension. Treatment with Orlistat should be discontinued after 12 weeks in patients who have not lost at least 5% of their body weight as measured at the start of drug therapy.
Adolescents (12 years & older): Obese adolescents should be treated with Orlistat only if an adequate reduction of body weight cannot be achieved by means of diet & increased physical activity. Treatment with orlistat should be considered in particular if complications of obesity are present.
Pharmacology
Orlistat is a potent, specific and long-acting lipase inhibitor. It exerts its therapeutic activity in the lumen of the stomach and upper small intestine by forming a covalent bond with the active serine site of gastric and pancreatic lipases. The inactivated enzyme is thus rendered unable to hydrolyze dietary fats in the form of triglycerides into absorbable free fatty acids and monoglycerides. As undigested triglycerides can not be absorbed, a caloric deficit arises which has a positive effect on weight control. Systemic absorption of orlistat is therefore not needed for the activity. At the recommended therapeutic dose of 120 mg three times a day, orlistat inhibit dietary fat absorption by approximately 30%.
Dosage & Administration
The recommended dose of Orlistat is one 120 mg capsule to be taken immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat the dose of Orlistat should be omitted. Doses of Orlistat above 120 mg three times daily have not been shown to provide additional benefits. The effect of Orlistat results in an increase in fecal fat 24-48 hours after dosing. Upon discontinuation of therapy, fecal fat content usually returns to pretreatment levels within 48-72 hours.
The safety & efficacy of Orlistat were investigated in clinical studies lasting up to 4 years. The recommended dose of Orlistat for adolescents is as same as adults.
Special dosage instruction: The tolerability and efficacy of Orlistat have not been studied in elderly patients, or patients with hepatic and/ or renal impairments.
Interaction
No interactions with commonly prescribed medications such as alcohol, digoxin, nifedipine, oral contraceptives, phenytoin, pravastatin, warfarin, or metformin, glibenclamide, fibrates, furosemide, captopril, or atenolol have been observed in studies.
Contraindications
Orlistat is contraindicated in patients with chronic malabsorption syndrome, in patients with cholestasis and in patients who are hypersensitive to orlistat or to any of the other ingredients of the capsules.
Side Effects
Common: Undesirable effects of Orlistat are largely gastrointestinal in nature. Common gastrointestinal side effects are oily spotting from the rectum, flatulence, fecal urgency, oily or fatty stool, abdominal discomfort etc.
Rare: Influenza, anxiety. headache, fatigue etc may rarely occur in some patients. Rare cases of hypersensitivity have been reported. Main clinical symptoms are pruritus, exanthema, urticaria, angioedema and anaphylaxis.
Pregnancy & Lactation
Use in pregnancy & lactation: No clinical data are available on pregnancy exposed to Orlistat. As it is not known whether Orlistat is excreted in breast milk. Orlistat should not be used during breastfeeding.
Precautions & Warnings
Organic causes of obesity (e.g. hypothyroidism) should be excluded before prescribing Orlistat. Orlistat and cyclosporine should not be coadministered. Cyclosporine should be taken at least 2 hours before or after Orlistat in patients taking both drugs. Cyclosporine level should be measured and frequently monitored.
In clinical trial, the decrease in body weight with Orlistat therapy was less in type II diabetic patients than in non-diabetic patients. Antidiabetic drug treatment should be closely monitored during Orlistat therapy. Because of the improvement in glycemic control, the dose of oral antidiabetics or of insulin may need to be adjusted.
Patients should be advised to adhere to the dietary recommendations. The probability of occurrence of gastrointestinal side effects may increase when Orlistat is taken with a fatty meal. The daily intake of fat should be distributed between three main meals. Patients should be strongly encouraged to take a multivitamin supplement that contains fat soluble vitamins to ensure adequate nutrition because orlistat has been shown to reduce the absorption of some fat soluble vitamins & beta-carotene. In addition, the levels of vitamin D & beta carotene may be low in obese patients compared with non-obese patients.
Overdose Effects
Single doses of 800 mg Orlistat and multiple doses of up to 400 mg three times a day for 15 days have been studied in normal weight and obese subjects without significant adverse findings.
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.
Alternative brands of Orlistat
Other brands with the same generic name, cheapest first.